Home
Forms Library
PNEUMOCOCCAL CONJUGATE VACCINE (PCV13)

PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) 2025

PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) Preview on Page 1

See details

4.4 out of 5

20 votes

The document outlines the recommendations and guidelines for administering the Pneumococcal Conjugate Vaccine (PCV13) by the Oregon Health Authority. It specifies that PCV13 is now a category A recommendation for children aged 6–18 with certain immunocompromising conditions. The document includes detailed instructions for healthcare providers on ordering, screening, administering the vaccine, and reporting adverse events, as well as information on contraindications, precautions, and recommended vaccination schedules.

Here's how it works

01. Edit your form online

Type text, add images, blackout confidential details, add comments, highlights and more.

02. Sign it in a few clicks

Draw your signature, type it, upload its image, or use your mobile device as a signature pad.

03. Share your form with others

Send it via email, link, or fax. You can also download it, export it or print it out.

How to rapidly redact PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) online

Ease of Setup

DocHub User Ratings on G2

Ease of Use

DocHub User Ratings on G2

Dochub is the best editor for updating your forms online. Adhere to this simple guideline redact PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) in PDF format online at no cost:

Register and log in. Register for a free account, set a strong password, and go through email verification to start managing your forms.
Add a document. Click on New Document and select the file importing option: upload PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) from your device, the cloud, or a protected URL.
Make changes to the sample. Utilize the top and left panel tools to change PNEUMOCOCCAL CONJUGATE VACCINE (PCV13). Add and customize text, pictures, and fillable areas, whiteout unnecessary details, highlight the significant ones, and comment on your updates.
Get your documentation accomplished. Send the sample to other people via email, create a link for quicker document sharing, export the sample to the cloud, or save it on your device in the current version or with Audit Trail included.

Try all the benefits of our editor right now!

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.

What disease does the PCV vaccine prevent?

The pneumococcal conjugate vaccines (PCV15, PCV20) and the pneumococcal polysaccharide vaccine (PPSV23) protect against pneumococcal infections. The bacteria that cause these infections spread through person-to-person contact.

What does PCV13 protect against?

Pneumococcal conjugate vaccine (called PCV13 or Prevnar 13) is recommended to protect infants and toddlers, and some older children and adults with certain health conditions, from pneumococcal disease. Pneumococcal disease is caused by infection with Streptococcus pneumoniae bacteria.

What disease does PCV13 protect against?

PPSV23 covers a greater number of pneumococcal serotypes but may not induce effective or lasting immunity. PCV13 seems to produce greater potential for immune memory.

What is the PCV13 conjugate vaccine?

Pneumococcal conjugate vaccine (PCV13, PCV15, PCV20, and PCV21) can prevent pneumococcal disease. Pneumococcal disease refers to any illness caused by pneumococcal bacteria. These bacteria can cause many types of illnesses, including pneumonia, which is an infection of the lungs.

What is PCV13 type disease?

Pneumococcal vaccine is an immunization against Streptococcus pneumoniae, a bacterium that frequently causes meningitis and pneumonia in the elderly, and people with chronic illnesses. Pneumococcal pneumonia accounts for 10% to 25% of all pneumonias.

Why is PCV13 no longer recommended?

PCV13 (pneumococcal conjugate vaccine) protects against 13 of the approximately 90 types of pneumococcal bacteria that can cause pneumococcal disease, including pneumonia, meningitis, and bacteremia.

What bacteria does Prevnar 13 cover?

Indications: Active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in children 6 weeks through 5 years of age (prior to the 6th birthday).

PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) 2025

Here's how it works